Assenagon Asset Management S.A. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$7,519,334
-30.5%
210,921
-10.0%
0.02%
-37.8%
Q2 2023$10,816,009
-34.9%
234,468
-43.4%
0.04%
-37.3%
Q1 2023$16,610,503
+224245.0%
414,227
+159.2%
0.06%
+118.5%
Q4 2022$7,404
-99.9%
159,819
-15.5%
0.03%
-10.0%
Q3 2022$7,830,000
+1169.0%
189,094
+1727.0%
0.03%
+1400.0%
Q2 2022$617,000
-29.8%
10,350
-1.0%
0.00%
-33.3%
Q4 2021$879,000
+7.1%
10,454
+14.8%
0.00%0.0%
Q3 2021$821,000
-90.1%
9,108
-84.8%
0.00%
-91.7%
Q4 2020$8,291,00059,8910.04%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2022
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$4,658,0002.63%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,364,434$84,745,0001.21%
CAPITAL INTERNATIONAL LTD /CA/ 259,700$16,130,0001.07%
Aureus Asset Management, LLC 65,670$4,079,0000.69%
Capital International Sarl 124,320$7,722,0000.67%
CAPITAL GUARDIAN TRUST CO 512,430$31,827,0000.58%
ROCKEFELLER FINANCIAL SERVICES INC 408,379$25,365,0000.50%
Rock Springs Capital Management LP 160,500$9,969,0000.50%
Hood River Capital Management LLC 112,296$6,975,0000.48%
Capital International, Inc./CA/ 52,700$3,273,0000.47%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders